Terms: = Breast cancer AND SMAD3, JV15-2, 4088, ENSG00000166949, P84022, Smad3, MADH3, HsT17436, Smad 3, DKFZp686J10186, HSPC193, DKFZP586N0721, MGC60396 AND Clinical Outcome
3 results:
1. The opposing effects of interferon-beta and oncostatin-M as regulators of cancer stem cell plasticity in triple-negative breast cancer.
Doherty MR; Parvani JG; Tamagno I; Junk DJ; Bryson BL; Cheon HJ; Stark GR; Jackson MW
Breast Cancer Res; 2019 Apr; 21(1):54. PubMed ID: 31036052
[TBL] [Abstract] [Full Text] [Related]
2. Roles of the WWOX in pathogenesis and endocrine therapy of breast cancer.
Li J; Liu J; Ren Y; Liu P
Exp Biol Med (Maywood); 2015 Mar; 240(3):324-8. PubMed ID: 25476151
[TBL] [Abstract] [Full Text] [Related]
3. An integrated genomic approach identifies persistent tumor suppressive effects of transforming growth factor-β in human breast cancer.
Sato M; Kadota M; Tang B; Yang HH; Yang YA; Shan M; Weng J; Welsh MA; Flanders KC; Nagano Y; Michalowski AM; Clifford RJ; Lee MP; Wakefield LM
Breast Cancer Res; 2014 Jun; 16(3):R57. PubMed ID: 24890385
[TBL] [Abstract] [Full Text] [Related]
